vs
Axil Brands, Inc.（AXIL）与RYTHM, Inc.（RYM）财务数据对比。点击上方公司名可切换其他公司
RYTHM, Inc.的季度营收约是Axil Brands, Inc.的1.3倍（$10.7M vs $8.1M），Axil Brands, Inc.净利率更高（8.7% vs -127.6%，领先136.3%），RYTHM, Inc.同比增速更快（242.0% vs 5.2%），过去两年RYTHM, Inc.的营收复合增速更高（102.6% vs 12.1%）
Axil Brands是一家总部位于美国的专业消费电子企业，主营高端听力防护设备、音频增强装置及个性化音频配件，旗下产品涵盖定制耳塞、运动蓝牙耳机等，面向全球普通消费者及专业作业群体销售。
RYTHM Inc.是一家临床阶段生物制药企业，专注于研发和商业化针对罕见遗传性内分泌与代谢疾病的创新疗法，主要面向美国市场，服务存在未被满足医疗需求的儿童及成人患者群体。
AXIL vs RYM — 直观对比
营收规模更大
RYM
是对方的1.3倍
$8.1M
营收增速更快
RYM
高出236.8%
5.2%
净利率更高
AXIL
高出136.3%
-127.6%
两年增速更快
RYM
近两年复合增速
12.1%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.1M | $10.7M |
| 净利润 | $704.9K | $-13.6M |
| 毛利率 | 68.1% | 75.5% |
| 营业利润率 | 11.1% | -121.5% |
| 净利率 | 8.7% | -127.6% |
| 营收同比 | 5.2% | 242.0% |
| 净利润同比 | 11.2% | 44.1% |
| 每股收益（稀释后） | $0.09 | $-6.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXILRYM
| Q4 25 | $8.1M | $10.7M | ||
| Q3 25 | $6.9M | $4.0M | ||
| Q2 25 | $5.8M | $2.0M | ||
| Q1 25 | $6.9M | $538.0K | ||
| Q4 24 | $7.7M | $-7.5M | ||
| Q3 24 | $5.9M | $1.9M | ||
| Q2 24 | $6.5M | $3.0M | ||
| Q1 24 | $6.5M | $2.6M |
净利润AXILRYM
| Q4 25 | $704.9K | $-13.6M | ||
| Q3 25 | $334.3K | $-10.7M | ||
| Q2 25 | $-245.6K | $-7.4M | ||
| Q1 25 | $576.7K | $-1.6M | ||
| Q4 24 | $633.7K | $-24.4M | ||
| Q3 24 | $-109.8K | $-18.7M | ||
| Q2 24 | $49.5K | $-3.0M | ||
| Q1 24 | $781.1K | $4.2M |
毛利率AXILRYM
| Q4 25 | 68.1% | 75.5% | ||
| Q3 25 | 67.6% | 34.0% | ||
| Q2 25 | 70.0% | 33.4% | ||
| Q1 25 | 71.7% | 16.7% | ||
| Q4 24 | 71.1% | — | ||
| Q3 24 | 71.0% | 11.6% | ||
| Q2 24 | 71.5% | 37.6% | ||
| Q1 24 | 71.5% | 6.4% |
营业利润率AXILRYM
| Q4 25 | 11.1% | -121.5% | ||
| Q3 25 | 6.0% | -219.8% | ||
| Q2 25 | 0.8% | -332.9% | ||
| Q1 25 | 8.4% | -687.9% | ||
| Q4 24 | 8.7% | — | ||
| Q3 24 | -2.4% | -63.1% | ||
| Q2 24 | 2.6% | -28.5% | ||
| Q1 24 | -1.6% | 13.6% |
净利率AXILRYM
| Q4 25 | 8.7% | -127.6% | ||
| Q3 25 | 4.9% | -263.8% | ||
| Q2 25 | -4.3% | -360.4% | ||
| Q1 25 | 8.3% | -302.2% | ||
| Q4 24 | 8.2% | 324.4% | ||
| Q3 24 | -1.9% | -964.4% | ||
| Q2 24 | 0.8% | -99.3% | ||
| Q1 24 | 12.1% | 163.0% |
每股收益（稀释后）AXILRYM
| Q4 25 | $0.09 | $-6.78 | ||
| Q3 25 | $0.04 | $-5.33 | ||
| Q2 25 | $-0.03 | $-3.74 | ||
| Q1 25 | $0.07 | $-0.83 | ||
| Q4 24 | $0.08 | $-24.26 | ||
| Q3 24 | $-0.02 | $-17.28 | ||
| Q2 24 | $0.11 | $-3.16 | ||
| Q1 24 | $0.04 | $3.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.0M | $32.2M |
| 总债务越低越好 | $138.3K | $80.6M |
| 股东权益账面价值 | $11.1M | $13.0M |
| 总资产 | $16.2M | $106.7M |
| 负债/权益比越低杠杆越低 | 0.01× | 6.19× |
8季度趋势，按日历期对齐
现金及短期投资AXILRYM
| Q4 25 | $5.0M | $32.2M | ||
| Q3 25 | $4.1M | — | ||
| Q2 25 | $4.8M | $41.0M | ||
| Q1 25 | $4.7M | $24.4M | ||
| Q4 24 | $5.2M | — | ||
| Q3 24 | $4.1M | $267.0K | ||
| Q2 24 | $3.3M | $57.0K | ||
| Q1 24 | $4.9M | $99.0K |
总债务AXILRYM
| Q4 25 | $138.3K | $80.6M | ||
| Q3 25 | $139.2K | $90.6M | ||
| Q2 25 | $140.2K | $40.6M | ||
| Q1 25 | $141.0K | $10.6M | ||
| Q4 24 | $143.3K | — | ||
| Q3 24 | $144.3K | $6.2M | ||
| Q2 24 | $146.6K | $4.6M | ||
| Q1 24 | — | — |
股东权益AXILRYM
| Q4 25 | $11.1M | $13.0M | ||
| Q3 25 | $10.2M | $11.7M | ||
| Q2 25 | $9.7M | $21.0M | ||
| Q1 25 | $9.7M | $26.8M | ||
| Q4 24 | $8.8M | $28.1M | ||
| Q3 24 | $7.9M | $5.5M | ||
| Q2 24 | $7.7M | $8.5M | ||
| Q1 24 | $8.8M | $-5.5M |
总资产AXILRYM
| Q4 25 | $16.2M | $106.7M | ||
| Q3 25 | $15.4M | $115.2M | ||
| Q2 25 | $12.9M | $69.5M | ||
| Q1 25 | $13.0M | $45.6M | ||
| Q4 24 | $13.7M | $54.0M | ||
| Q3 24 | $11.4M | $39.0M | ||
| Q2 24 | $11.0M | $39.4M | ||
| Q1 24 | $12.7M | $40.6M |
负债/权益比AXILRYM
| Q4 25 | 0.01× | 6.19× | ||
| Q3 25 | 0.01× | 7.73× | ||
| Q2 25 | 0.01× | 1.94× | ||
| Q1 25 | 0.01× | 0.40× | ||
| Q4 24 | 0.02× | — | ||
| Q3 24 | 0.02× | 1.13× | ||
| Q2 24 | 0.02× | 0.54× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $934.8K | $-3.0M |
| 自由现金流经营现金流 - 资本支出 | $906.4K | — |
| 自由现金流率自由现金流/营收 | 11.1% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | 1.33× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AXILRYM
| Q4 25 | $934.8K | $-3.0M | ||
| Q3 25 | $-739.2K | $-5.4M | ||
| Q2 25 | $194.4K | $-8.4M | ||
| Q1 25 | $-169.9K | $-6.7M | ||
| Q4 24 | $1.0M | $-5.3M | ||
| Q3 24 | $897.3K | $-1.4M | ||
| Q2 24 | $-336.6K | $-1.8M | ||
| Q1 24 | $-912.8K | $-3.0M |
自由现金流AXILRYM
| Q4 25 | $906.4K | — | ||
| Q3 25 | $-747.6K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-258.2K | — | ||
| Q4 24 | $941.1K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-394.9K | $-1.8M | ||
| Q1 24 | $-922.1K | $-3.0M |
自由现金流率AXILRYM
| Q4 25 | 11.1% | — | ||
| Q3 25 | -10.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -3.7% | — | ||
| Q4 24 | 12.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6.1% | -61.2% | ||
| Q1 24 | -14.3% | -115.1% |
资本支出强度AXILRYM
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.9% | 0.1% | ||
| Q1 24 | 0.1% | 0.1% |
现金转化率AXILRYM
| Q4 25 | 1.33× | — | ||
| Q3 25 | -2.21× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.29× | — | ||
| Q4 24 | 1.59× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6.80× | — | ||
| Q1 24 | -1.17× | -0.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXIL
| Hearing Enhancement And Protection | $7.8M | 95% |
| Other | $378.9K | 5% |
RYM
| Nonlicensing Revenue | $9.5M | 89% |
| Cultivation Business Discontinued Operations | $1.2M | 11% |
